Table of Contents:
  • Contents: Fluid biomarker candidates for neurodegenerative disease
  • Amyloid pathology
  • CSF and plasma/serum NfL
  • CSF Aβ42 in Alzheimer's disease and neuroinflammatory diseases
  • Tau pathology in Alzheimer's disease
  • Neurodegeneration
  • CSF and plasma NfL as biomarkers for disease progression
  • Drug treatment and NfL levels